Akin advised Pharmakon Advisors on the deal. Pharmakon Advisors, LP, a leading investor in non-dilutive debt for the life sciences industry, announced its $450 million financing commitment...
You must be a Standard 1 Year member to access this content.
Fenwick advised Pharmakon on the deal while Akin Gump advised Pharmakon Advisors. Pharmakon, an investor in non-dilutive debt for the life sciences industry and the investment...
You must be a Standard 1 Year member to access this content.
Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...
You must be a Standard 1 Year member to access this content.
Akin Gump Strauss Hauer & Feld LLP advised BioPharma Credit PLC on the deal, while Dechert LLP advised Pharmakon Advisors LP. LumiraDx has secured new financing commitments...
You must be a Standard 1 Year member to access this content.
